Related references
Note: Only part of the references are listed.Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Ralf Weiskirchen et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel et al.
HEPATOLOGY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation
Akiko Eguchi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening
Patrick Marcellin et al.
LIVER INTERNATIONAL (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Yaron Rotman et al.
GUT (2017)
Global epidemiology and burden of HCV infection and HCV-related disease
Aaron P. Thrift et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Can a fibrotic liver afford epithelial-mesenchymal transition?
Stefan Munker et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
Stefania Cannito et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents
Katrin Bottcher et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Liver macrophages in tissue homeostasis and disease
Oliver Krenkel et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Inhibition of SIRT2 suppresses hepatic fibrosis
Maribel Arteaga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein
Xing Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro
Quanfang Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
The PDGF system and its antagonists in liver fibrosis
Erawan Borkham-Kamphorst et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
The Pathogenesis of Autoimmune Liver Disease
Katherine Arndtz et al.
DIGESTIVE DISEASES (2016)
The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells
Saeideh Nakhaei-Rad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
Ralf Weiskirchen
FRONTIERS IN PHARMACOLOGY (2016)
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
Shuang Liang et al.
FRONTIERS IN PHYSIOLOGY (2016)
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
Roser Busca et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Characterization of Binding Mode of Action of a Blocking Anti-Platelet-Derived Growth Factor (PDGF)-B Monoclonal Antibody, MOR8457, Reveals Conformational Flexibility and Avidity Needed for PDGF-BB To Bind PDGF Receptor-beta
Jun Kuai et al.
BIOCHEMISTRY (2015)
PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β
Erawan Borkham-Kamphorst et al.
CELLULAR SIGNALLING (2015)
Global Epidemiology of Hepatocellular Carcinoma An Emphasis on Demographic and Regional Variability
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2015)
Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice
Ahmed Bettaieb et al.
GASTROENTEROLOGY (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis
Peri Kocabayoglu et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
Origin and Function of Myofibroblasts in the Liver
Rebecca Wells et al.
SEMINARS IN LIVER DISEASE (2015)
Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells
Mar Coll et al.
SCIENTIFIC REPORTS (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
Tian Lan et al.
PLOS ONE (2015)
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
Claudia Bocca et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Role of NADPH Oxidases in Liver Fibrosis
Yong-Han Paik et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Cellular and molecular mechanisms in liver fibrogenesis
Erica Novo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
The global burden of liver disease: a challenge for methods and for public health
Peter Byass
BMC MEDICINE (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Evidence for and against epithelial-to-mesenchymal transition in the liver
Guanhua Xie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Origins and functions of liver myofibroblasts
Sara Lemoinne et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases
Mohamed E. Shaker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Beyond scoring: a modern interpretation of disease progression in chronic liver disease
Matteo Rosselli et al.
GUT (2013)
Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptorinduced TIMP-1 gene transcription in hepatic stellate cells in mice
Maria J. Perugorria et al.
HEPATOLOGY (2013)
Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury
Yuchang Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HDAC inhibitors in experimental liver and kidney fibrosis
Katrien Van Beneden et al.
FIBROGENESIS & TISSUE REPAIR (2013)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent
Tomonori Aoyama et al.
HEPATOLOGY (2012)
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells
Erica Novo et al.
JOURNAL OF PATHOLOGY (2012)
SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF
Catalina Atorrasagasti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Liver fibrogenic cells
Stuart J. Forbes et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Alexander Plotnikov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Tp12 kinase signal transduction in inflammation and cancer
Maria Vougioukalaki et al.
CANCER LETTERS (2011)
Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression
Mohamed E. Shaker et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells
Erica Novo et al.
JOURNAL OF HEPATOLOGY (2011)
Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib
Yuqing Liu et al.
JOURNAL OF HEPATOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C
M. L. Shiffman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Anti-PDGF-B monoclonal antibody reduces liver fibrosis development
Shinji Ogawa et al.
HEPATOLOGY RESEARCH (2010)
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Yan Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Profiling the Human Protein-DNA Interactome Reveals ERK2 as a Transcriptional Repressor of Interferon Signaling
Shaohui Hu et al.
CELL (2009)
Inhibition of Extracellular Signal-Regulated Kinase 1 by Adenovirus Mediated Small Interfering RNA Attenuates Hepatic Fibrosis in Rats
Wei Zhong et al.
HEPATOLOGY (2009)
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
Marco Trappoliere et al.
JOURNAL OF HEPATOLOGY (2009)
Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells
Junji Ma et al.
LIVER INTERNATIONAL (2009)
Cell fate decisions are specified by the dynamic ERK interactome
Alex von Kriegsheim et al.
NATURE CELL BIOLOGY (2009)
Targeted inhibition of platelet-derived growth factor receptor-β subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats
S-W Chen et al.
GENE THERAPY (2008)
Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats
Alejandra M. Camino et al.
JOURNAL OF GENE MEDICINE (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
RNA interference targeting the platelet-derived growth factor receptor β subunit ameliorates experimental hepatic fibrosis in rats
Si-Wen Chen et al.
LIVER INTERNATIONAL (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
Canonical and alternative MAPK signaling
Genaro Pimienta et al.
CELL CYCLE (2007)
The MEK/ERK cascade: From signaling specificity to diverse functions
Yoav D. Shaul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C
Paul J. Pockros et al.
HEPATOLOGY (2007)
Pro-fibrogenic potential of PDGF-D in liver fibrosis
Erawan Borkham-Kamphorst et al.
JOURNAL OF HEPATOLOGY (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARγ in rat activated hepatic stellate cell in vitro
Yajun Zhou et al.
LABORATORY INVESTIGATION (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Dynamic expression of extracellular signal-regulated kinase in rat liver tissue during hepatic fibrogenesis
Xiao-Lan Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans
E. Novo et al.
GUT (2006)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells
E Novo et al.
GUT (2006)
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
M Neef et al.
JOURNAL OF HEPATOLOGY (2006)
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats
H Yoshiji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis
E Borkham-Kamphorst et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid
S Reif et al.
JOURNAL OF HEPATOLOGY (2004)
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
E Borkham-Kamphorst et al.
LABORATORY INVESTIGATION (2004)
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells
E Zamara et al.
JOURNAL OF HEPATOLOGY (2004)
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2
K Lorenz et al.
NATURE (2003)
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein
KC Corbit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity
KY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oxidative stress-related molecules and liver fibrosis
M Parola et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
